Document Detail


Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links.
MedLine Citation:
PMID:  17707576     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Erectile dysfunction (ED) may be the early clinical manifestation of a generalized vascular disease and carries an independent risk for cardiovascular events. Low-grade subclinical inflammation affects endothelial function and is involved in all stages of the atherosclerotic process. This review identifies potential pathophysiologic links among low-grade inflammation, ED, metabolic syndrome, and coronary artery disease (CAD) and presents the clinical implications in terms of ED diagnosis, assessment of patient risk, and therapy. METHODS: A comprehensive evaluation was performed for available published data in full-length papers that were identified in MedLine up to July 2007. RESULTS: Studies support an association between metabolic syndrome, ED, and increased inflammatory state. Increased circulating levels of inflammatory and endothelial-prothrombotic compounds are related to the presence and severity of ED. Specific inflammatory biomarkers and their combination appear to have the potential to aid ED diagnosis or exclusion. ED and CAD may confer a similar unfavorable impact on the inflammatory and prothrombotic state, whereas ED adds an incremental activation on top of CAD; these findings have important implications for cardiovascular risk. Lifestyle and risk factor modification, as well as pharmacologic therapy, are associated with anti-inflammatory effects. CONCLUSIONS: Low-grade systemic inflammation could be an important element of the association between metabolic syndrome, ED, and CAD. Its individualized assessment may be a valuable tool for ED diagnosis, risk assessment, and rationalized therapeutic approach especially in patients with ED who have metabolic syndrome and carry an intermediate risk for future cardiovascular events.
Authors:
Charalambos Vlachopoulos; Konstantinos Rokkas; Nikolaos Ioakeimidis; Christodoulos Stefanadis
Related Documents :
11466656 - Hypothenar hammer syndrome after radial forearm flap harvest: a case report.
19155656 - Prevalence of coronary artery disease in low to moderate-risk asymptomatic women: a mul...
21078786 - Endothelial dysfunction in systemic lupus erythematosus: evaluation with 13n-ammonia pet.
14564976 - Gender differences in diagnostic procedures.
16125806 - Depressive symptomatology at age 75 and subsequent use of health and social services.
19443806 - Predictors of smoking abstinence after first-ever ischemic stroke: a 3-month follow-up.
Publication Detail:
Type:  Journal Article; Review     Date:  2007-08-13
Journal Detail:
Title:  European urology     Volume:  52     ISSN:  0302-2838     ISO Abbreviation:  Eur. Urol.     Publication Date:  2007 Dec 
Date Detail:
Created Date:  2007-11-12     Completed Date:  2008-01-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7512719     Medline TA:  Eur Urol     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  1590-600     Citation Subset:  IM    
Affiliation:
Cardiovascular Diseases and Sexual Health Unit, 1st Department of Cardiology, Athens Medical School, Hippokration Hospital, Athens, Greece. cvlachop@otenet.gr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Atherosclerosis / etiology
Coronary Artery Disease / etiology*
Endothelium, Vascular / physiology
Erectile Dysfunction / diagnosis,  etiology*,  therapy
Humans
Inflammation / complications*
Male
Metabolic Syndrome X / complications*
Prognosis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Indicators for managing biosolids in Ireland.
Next Document:  Real-time MRI of orthotopic ileal neobladder voiding: preliminary findings.